Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

about

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q50141495

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@en

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@nl

type

Item

label

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@en

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@nl

prefLabel

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@en

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@nl

P1476

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension.

@en

P2093

Haiyang Tang

http://www.w3.org/2001/XMLSchema#string

Jason X-J Yuan

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Rebecca R Vanderpool

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of transition studies of pulmonary arterial hypertension specific medications

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.

Effects of tetrahydrobiopterin oral treatment in hypoxia-induced pulmonary hypertension in rat.

Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension.

Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.

Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.

P304

569-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/2045893217728261

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28895506

http://www.w3.org/2001/XMLSchema#string

P932

5841892

http://www.w3.org/2001/XMLSchema#string